Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

Sunpharma Site 39, Phillip

Sunpharma Site 20, Seoul

Sunpharma Site 16, Maroochydore

Sunpharma Site 19, Seoul

Sunpharma site no. 08, Hobart

Sunpharma Site 73, Berlin

Sunpharma Site 97, Prague

Sunpharma Site 71, Córdoba

Sunpharma Site 75, A Coruña

Sunpharma Site 18, Incheon

Sunpharma Site 100, Madrid

Sunpharma site no. 11, Greenville

Sunpharma site no. 04, Miami Beach

Sunpharma site no. 07, Tamarac

Sunpharma site no. 02, New Port Richey

Sunpharma Site 72, Seville

Sunpharma Site 92, Herne

Sunpharma Site 76, Valencia

Sunpharma site no. 05, Springfield

Sunpharma site no. 10, Lincoln

Sunpharma site no. 14, Lake Charles

Sunpharma site no. 01, Tomball

Sunpharma site no. 03, San Antonio

Sunpharma site no. 09, Lubbock

Sunpharma site no. 12, Covina

Sunpharma site no. 06, Spokane

Sunpharma Site 106, Lucknow

Sunpharma Site 111, Surat

Sunpharma Site 108, Pune

Sunpharma Site 112, Hyderabad

Sunpharma Site 110, Bangalore

Sunpharma Site 109, Hubli

Sunpharma Site 107, Belagavi

Sunpharma Site 113, Kochi

Sunpharma Site 64, Brno

Sunpharma Site 102, Prague

Sunpharma Site 63, Zlín

Sunpharma Site 84, Nagoya

Sunpharma Site 89, Kitakyushu

Sunpharma Site 22, Kitakyushu-shi

Sunpharma Site 86, Sendai

Sunpharma Site 24, Miyazaki

Sunpharma Site 91, Mitaka

Sunpharma Site 85, Shinjuku

Sunpharma Site 90, tabashi City

Sunpharma Site 88, Kumamoto

Sunpharma Site 87, Osaka

Sunpharma Site 23, Tsu

Sunpharma Site 93, Bialystok

Sunpharma Site 95, Bialystok

Sunpharma Site 94, Lublin

Sunpharma Site 74, Poznan

Sunpharma Site 96, Warsaw